Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends cabozantinib for advanced renal cell cancer

europeanpharmaceuticalreviewJuly 11, 2017

Tag: NICE , renal cell cancer , cabozantinib

PharmaSources Customer Service